NEW YORK (GenomeWeb) – Lucigen this week announced an exclusive distribution agreement with Sigma-Aldrich's Indian subsidiary. 

The deal with Sigma-Aldrich Chemicals Private expands the market for Lucigen's life science reagents in that country, the Middleton, Wisconsin-based firm said. Financial and other terms of the agreement were not disclosed. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.